share_log

ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eli Lilly and Company(16.6%)

ProQR Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Eli Lilly and Company(16.6%)

美股SEC公告 ·  2022/12/23 16:39
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息